Written Question·Department of Health and Social Care·UIN HL1759
Breast Cancer
Tabled: 7 July 2026
Answered: 16 July 2026
Question
To ask His Majesty's Government what assessment they have made of the medicines available to treat patients with HER2-low metastatic breast cancer.
Answer
HER2‑low breast cancer is managed with treatments for HER2‑negative breast cancer. The National Institute for Health and Care Excellence (NICE) has published guidance recommending a number of medicines for the treatment of HER2-negative breast cancer whic...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN HL1759) →